WeightWatchers Gets a Makeover With Obesity-Drug Business

[ad_1] Markets Heard on the Street The decision to get into the business for drugs such as Ozempic makes sense [ad_2] Source link

Eli Lilly Is Priced for Perfection in the Obesity Market

[ad_1] The company has outperformed its pharma peers in recent years, but its valuation leaves little room for error. [ad_2] Source link

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%

[ad_1] Health Sanofi says it would cap patients’ out-of-pocket costs for Lantus insulin at $35 a month [ad_2] Source link

Eli Lilly Drug Fails to Prevent Alzheimer’s in Study

[ad_1] Business Health Care Health The drug was no better than placebo at averting the condition [ad_2] Source link

Eli Lilly’s Insulin Decision Puts Others in Hot Seat

[ad_1] The drugmaker’s plan moves the spotlight to industry middlemen, who face a barrage of investigations. [ad_2] Source link

Eli Lilly to Cut Prices of Insulin Drugs by 70%, Cap Patient Costs at $35

[ad_1] Facing pressure to curb diabetes-treatment costs, the company will cut the list prices for its most commonly prescribed insulin and take other steps to make it easier for patients…

Ozempic Runs Low for Diabetes Patients as Weight-Loss Use Surges

[ad_1] Health Some diabetes patients have had to reduce Ozempic dosing or switch to alternatives [ad_2] Source link

Why Obesity-Drug Makers Just Lost Weight

[ad_1] Markets Heard on the Street Novo Nordisk and Eli Lilly are working to ramp up capacity, insurance coverage [ad_2] Source link

Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint

[ad_1] Health List prices climb by 5.6% on average as new federal law aims to lower drug costs [ad_2] Source link

Eli Lilly Earnings Show 9% Sales Drop on Covid-19 Treatment Decline

[ad_1] Business Earnings Strong dollar, lower realized prices also weigh on top line [ad_2] Source link